Navigation Links
Gallo Research Center announces new round of awards for $20m US Army-funded research program
Date:10/19/2013

The UCSF-affiliated Ernest Gallo Clinic and Research Center has issued a second round of grants under its U.S. Army-funded research program intended to accelerate the discovery and development of new medications to treat alcohol and substance abuse in the context of post-traumatic stress and combat injury.

The program, known as the Institute for Molecular Neuroscience (IMN), relies on the expertise of a team of national experts who are unaffiliated with grant applicants to conduct an independent peer-review process.

The second round of pilot research grants will support a broad range of projects to investigate potential new treatments for substance abuse, traumatic brain injury and post-traumatic stress. The total funding for this round of awards is $1.25 million. Together with the $3.7 million awarded in round one, the IMN has to date awarded approximately $5 million in proof-of-principle grants.

The IMN Program represents an important new strategy for combating substance abuse and related post-traumatic stress or other combat injuries, said John A. De Luca, PhD, chairman of the board and president of the Gallo Center. These medical conditions are national security health issues. The IMN seeks to address these problems through its multidisciplinary, competitive national research program.

Grant recipients in this round of funding are:

Michael E. Charness

Boston VA Research Institute (Harvard)

$300,000

Lori A. Knackstedt

University of Florida

$306,207

Kenneth M. Lattall

Oregon Health and Science University

$370,881

Eric P. Zorilla

The Scripps Research Institute

$273,088

It is gratifying that Congress and the Defense Department have embraced the IMN Program and its new approach to accelerating the discovery of new medications to address substance abuse, post-traumatic stress and other conditions facing our military personnel and veterans, said William R. Sawyers, chief administrative officer of the IMN and the Gallo Center.

The UCSF-affiliated Gallo Research Center was selected to manage the IMN Program in recognition of its expertise in the neurobiology of addiction and in managing large research projects. The strategy of the IMN, which funds short-term pilot projects, and then selects only the most compelling for advancement, represents a new approach to the development of medications for the U.S. Military.

The IMN Program is comprised of a consortium of 18 leading research universities and research institutions across the country. Institutions which have received IMN funding previously include Columbia University, Oregon Health and Science University, the Medical University of South Carolina, Yale University, the University of Texas, Austin, the Northern California Institute for Research and Education (NCIRE) and UCSF.

Congressional appropriations for the IMN Program to date total $20.1 million, said De Luca. Later this year, the IMN will select the most promising of its first round of pilot projects to be advanced into the next stage of medications development, said Sawyers.


'/>"/>

Contact: Peter Farley
peter.farley@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert  

Related medicine news :

1. Gallo Research Center to lead $15 million US Army-funded national research program
2. Increasing dopamine in frontal cortex decreases impulsive tendency, UCSF-Gallo scientists find
3. Increasing dopamine in brains frontal cortex decreases impulsive tendency, UCSF-Gallo study finds
4. Does gallows humor among physicians encourage accusations of murder and euthanasia?
5. A Milestone: Pool Services Technologies Just Conserved 7.5 Million Gallons of Water in San Diego
6. Gallo Center study in mice links cocaine use to new brain structures
7. Automotive Paints Market Worth 998.7 Million Gallons by 2018 with Revenue of $11.7 Billion - New Report by MarketsandMarkets
8. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
9. NIH awards $20 million over 5 years to train next generation of global health researchers
10. Researchers develop a new cell and animal model of inflammatory breast cancer
11. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gallo Research Center announces new round of awards for $20m US Army-funded research program
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD is dual ... City. He is known for his distinguished expertise and experience in the diagnosis and ... sub-specialty training in treating renovascular disease and aortic aneurysm . He is known ...
(Date:5/24/2017)... Cincinnati, OH (PRWEB) , ... May 24, 2017 , ... ... discreet and comfortable ClearCorrect orthodontics, with or without a referral. Dr. Kejriwal ... is why she offers convenient, clear braces in Cincinnati, OH. Patients no longer need ...
(Date:5/24/2017)... Las Vegas, NV (PRWEB) , ... May 24, ... ... Las Vegas, NV, recently completed Course II of the HP3 (High-Performance Periodontal Practice) ... commits himself to learning the latest advancements in his field by attending numerous ...
(Date:5/24/2017)... ... , ... If you are thinking of a visit to San Francisco , fall is ... perfect time to visit. , Business Architecture Associates is pleased to offer 5 days of ... a 4-½ day package for individuals, and as 4-½ day corporate package for up to ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... label food ingredient solutions for the food and beverage industry offers Citri-Fi®, a ... ingredient statements during the purchasing decision process. As a result, labels need to ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
(Date:5/9/2017)... May 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of ... Canadian Intellectual Property Office has granted Oramed a ... of Exenatide". The patent covers Oramed,s invention of ... GLP-1 is an incretin hormone that stimulates the ...
(Date:5/8/2017)... NEW YORK , May 8, 2017 ... in the transition from fee for service reimbursement. Black ... April 2017. 1.       The Market for ... 77% of physician practices with 3 or ... Compliance Technology Solutions by Q4. "Given the magnitude of ...
Breaking Medicine Technology: